An early study has identified that RARα overexpression alleviated hepatic steatosis via suppressing HNF4α-regulated PPARγ expression [19], but whether CD36 is involved in RARα’s regulation on hepatic lipid metabolism is unknown. The gene discussed is PPARG; the disease is fatty liver disease.